Movano INC 8-K filings

NASDAQ
Movano Inc. has amended its At-the-Market Issuance Agreement, replacing B. Riley Securities with JonesTrading Institutional Services as the sales agent.
NASDAQ
Movano Health announced its Q1 2024 financial results, highlighted by a $24.1 million private placement and progress towards FDA clearance for its Evie Med Ring.
NASDAQ
Movano Health announced a $24 million private placement, 2023 financial results, and progress towards FDA clearance for its Evie Med device.
NASDAQ
Movano Inc. has entered into a securities purchase agreement for a private placement of units consisting of common stock or pre-funded warrants and common stock purchase warrants, aiming to raise up to $42.6 million.